
CAS Number338736-46-2
Synonyms6-Methoxy-N-(4-methoxyphenyl)-4-quinazolinamine hydrochloride (1:1); (4-methoxy-phenyl)-(6-methoxy-quinazolin-4-yl)-amine HCl; 6-Methoxy-N-(4-methoxyphenyl)quinazolin-4-amine hydrochloride (1:1); 4-Quinazolinamine, 6-methoxy-N-(4-methoxyphenyl)-, hydrochloride (1:1)
Molecular FormulaC18H21O1N3Cl1F3
Molecular Weight387.83
Appearancesolid
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 338736-46-2 |
| Catalog No. | 2A-1173985 |
| Chinese Name | LY 456236 |
| Synonyms | 6-Methoxy-N-(4-methoxyphenyl)-4-quinazolinamine hydrochloride (1:1); (4-methoxy-phenyl)-(6-methoxy-quinazolin-4-yl)-amine HCl; 6-Methoxy-N-(4-methoxyphenyl)quinazolin-4-amine hydrochloride (1:1); 4-Quinazolinamine, 6-methoxy-N-(4-methoxyphenyl)-, hydrochloride (1:1) |
| Molecular Formula | C18H21O1N3Cl1F3 |
| Molecular Weight | 387.83 |
| Appearance | solid |
| Storage Condition | 2-8°C |
| Application | LY456236 is a selective, non-competitive and orally active mGlu1 receptor antagonist that inhibits phosphoinositide hydrolysis with an IC50 of 0.145 μM. LY456236 also inhibits EGFR, with an IC50 of 0. |
| PubChem ID | 14899189 |
| MDL Number | MFCD31619246 |
| SMILES | COc1ccc(Nc2ncnc3ccc(OC)cc23)cc1.Cl |
| InChI | InChI=1S/C16H15N3O2.ClH/c1-20-12-5-3-11(4-6-12)19-16-14-9-13(21-2)7-8-15(14)17-10-18-16;/h3-10H,1-2H3,(H,17,18,19);1H |
| InChI Key | AVKFOWUSTVWZQN-UHFFFAOYSA-N |
| Hazard Symbols | transportation |
| MSDS | msds/174319_1_338736_46_2.pdf |
| Bioactivity | LY456236 is a selective, non-competitive and orally active mGlu1 receptor antagonist that inhibits phosphoinositide hydrolysis with an IC50 of 0.145 μM. LY456236 also inhibits EGFR with an IC50 of 0.91 μM[1][3]. Related Catalog Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR Signaling Pathways >> GPCR/G Protein >> mGluR Research Areas >> Neurological Disease Target IC50: 0.145 μM (mGlu1), 0.91 μM (EGFR)[1] In Vitro LY456236 (2 μM; 30 min) Reduces DHPG (HY-12598A) stimulates OCCM-30 proliferation[2]. Cell Proliferation Assay[2] Cell Line: OCCM-30 cells Concentration: 2 μM Incubation Time: 30 min, followed by 72 h incubation with DHPG (HY-12598A) Result: Reduced DHPG-stimulated OCCM-30 proliferation. In Vivo LY456236 in mice (3-100 mg/kg; i.p.; once) and rats (10-60 mg/kg; oral; once) shows anticonvulsant effects. Animal Model: DBA/2 mice and CD1 mice, seizure models[3] Dosage: 3-100 mg/kg Administration: IP, once Result: Produced dose-related anticonvulsant effects in preventing audiogenic-induced (tonic-clonic) seizures in DBA/2 mice, threshold electroshock-induced seizures in CD1 mice, and 6 Hz electroshock-induced seizures in CD1 mice. Animal Model: Amygdala-kindled Sprague-Dawley rats[3] Dosage: 10, 30 and 60 mg/kg Administration: Oral, once Result: Produced dose-related decreases in behavioral and electrographic seizures at threshold stimulus intensity. Produced a dose-related increase in the stimulus intensity required to produce generalized seizures. References [1]. Ravikumar B, et al. Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies. Cell Chem Biol. 2019 Nov 21;26(11):1608-1622.e6. [2]. Kanaya S, et al. Metabotropic glutamate receptor 1 promotes cementoblast proliferation via MAP kinase signaling pathways. Connect Tissue Res. 2016 Sep;57(5):417-26. [3]. Shannon HE, et al. Anticonvulsant effects of LY456236, a selective mGlu1 receptor antagonist. Neuropharmacology. 2005;49 Suppl 1:188-95. Chemical & Physical Properties Molecular Formula C16H16ClN3O2 Molecular Weight 317.770 Exact Mass 317.093109 PSA 56.27000 LogP 4.26560 InChIKey AVKFOWUSTVWZQN-UHFFFAOYSA-N SMILES COc1ccc(Nc2ncnc3ccc(OC)cc23)cc1.Cl Storage condition 2-8°C |
| Use of | LY456236 is a selective, non-competitive and orally active mGlu1 receptor antagonist that inhibits phosphoinositide hydrolysis with an IC50 of 0.145 μM. LY456236 also inhibits EGFR with an IC50 of 0.91 μM[1][3]. Properties Name 6-Methoxy-N-(4-methoxyphenyl)-4-quinazolinamine hydrochloride (1: 1) Synonym More Synonyms LY 456236 Biological Activity Description LY456236 is a selective, non-competitive and orally active mGlu1 receptor antagonist that inhibits phosphoinositide hydrolysis with an IC50 of 0.145 μM. LY456236 also inhibits EGFR with an IC50 of 0.91 μM[1][3]. Related Catalog Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR Signaling Pathways >> GPCR/G Protein >> mGluR Research Areas >> Neurological Disease IC50: 0.145 μM (mGlu1), 0.91 μM (EGFR)[1] References [1]. Ravikumar B, et al. Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies. Cell Chem Biol. 2019 Nov 21;26(11):1608-1622.e6. [2]. Kanaya S, et al. Metabotropic glutamate receptor 1 promotes cementoblast proliferation via MAP kinase signaling pathways. Connect Tissue Res. 2016 Sep;57(5):417-26. [3]. Shannon HE, et al. Anticonvulsant effects of LY456236, a selective mGlu1 receptor antagonist. Neuropharmacology. 2005;49 Suppl 1:188-95. Chemical & Physical Properties Exact Mass 317.093109 PSA 56.27000 LogP 4.26560 InChIKey AVKFOWUSTVWZQN-UHFFFAOYSA-N |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available If applicable, the chemical meets the requirements of the Regulations on the Safety Management of Hazardous Chemicals (adopted by the State Council on January 9, 2002). |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| {4-[2-(4-Benzoyl-phenoxy)-ethoxy]-phenyl}-phenyl-methanone | 5410-01-5 | 2A-1173977 |
| 4-Chloro-quinazolin-8-ol | 154288-08-1 | 2A-1173980 |
| 2-Cyano-4,4-dimethyl-pent-2-enoic acid | 88319-37-3 | 2A-1173982 |
| 2-[4-(6-Benzyl-4,5-dimethyl-pyridazin-3-yl)-2-methyl-3,4,5,6-tetrahydro-2H-[1,2']bipyrazinyl-5'-yl]-propan-2-ol | 1204975-42-7 | 2A-1173983 |
| 3-Hydroxy-2-phenyl-propanamide | 56598-62-0 | 2A-1173984 |
| 2-Chloro-N-[3-chloro-4-(4-chloro-1,3-dioxo-1,3-dihydro-isoindol-2-yl)-phenyl]-nicotinamide | 1623101-11-0 | 2A-1173986 |
| 2-Chloro-5-iodonicotinic acid | 59782-86-4 | 2A-1173988 |
| 1-bromo-3,3-dimethyl-2-butanol | 1438-13-7 | 2A-1173829 |
| 4-CHLORO-D-PHENYLALANINE HYDROCHLORIDE | 147065-05-2 | 2A-1173990 |
| Cbz-4-Bromo-D-Phenylalanine | 1100357-99-0 | 2A-1173992 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA